|
1
|
Goadsby PJ: Recent advances in
understanding migraine mechanisms, molecules and therapeutics.
Trends Mol Med. 13:39–44. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Noseda R and Burstein R: Migraine
pathophysiology: Anatomy of the trigeminovascular pathway and
associated neurological symptoms, cortical spreading depression,
sensitization, and modulation of pain. Pain. 154(Suppl 1): S44–S53.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ho TW, Edvinsson L and Goadsby PJ: CGRP
and its receptors provide new insights into migraine
pathophysiology. Nat Rev Neurol. 6:573–582. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Russo AF: Calcitonin gene-related peptide
(CGRP): A new target for migraine. Annu Rev Pharmacol Toxicol.
55:533–552. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Villalón CM and Olesen J: The role of CGRP
in the pathophysiology of migraine and efficacy of CGRP receptor
antagonists as acute antimigraine drugs. Pharmacol Ther.
124:309–323. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Goadsby PJ, Edvinsson L and Ekman R:
Release of vasoactive peptides in the extracerebral circulation of
humans and the cat during activation of the trigeminovascular
system. Ann Neurol. 23:193–196. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Goadsby PJ: New targets in the acute
treatment of headache. Curr Opin Neurol. 18:283–288. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Goadsby PJ: Post-triptan era for the
treatment of acute migraine. Curr Pain Headache Rep. 8:393–398.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fredholm BB, IJzerman AP, Jacobson KA,
Klotz KN and Linden J: International Union of Pharmacology. XXV.
Nomenclature and classification of adenosine receptors. Pharmacol
Rev. 53:527–552. 2001.PubMed/NCBI
|
|
10
|
Gao H, Yu Z, Ma K and Han G: Tianshu
capsule for migraine: A systemic review. Chin Tradit Pat Med.
36:1156–1160. 2014.
|
|
11
|
Messlinger K: Migraine: Where and how does
the pain originate? Exp Brain Res. 196:179–193. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Moreno MJ, Abounader R, Hébert E, Doods H
and Hamel E: Efficacy of the non-peptide CGRP receptor antagonist
BIBN4096BS in blocking CGRP-induced dilations in human and bovine
cerebral arteries: Potential implications in acute migraine
treatment. Neuropharmacology. 42:568–576. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gibson SJ, Polak JM, Bloom SR, Sabate IM,
Mulderry PM, Ghatei MA, McGregor GP, Morrison JF, Kelly JS, Evans
RM, et al: Calcitonin gene-related peptide immunoreactivity in the
spinal cord of man and of eight other species. J Neurosci.
4:3101–3111. 1984.PubMed/NCBI
|
|
14
|
Fischer MJ, Koulchitsky S and Messlinger
K: The nonpeptide calcitonin gene-related peptide receptor
antagonist BIBN4096BS lowers the activity of neurons with meningeal
input in the rat spinal trigeminal nucleus. J Neurosci.
25:5877–5883. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sjölund KF, Belfrage M, Karlsten R,
Segerdahl M, Arnér S, Gordh T and Solevi A: Systemic adenosine
infusion reduces the area of tactile allodynia in neuropathic pain
following peripheral nerve injury: A multi-centre,
placebo-controlled study. Eur J Pain. 5:199–207. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Poon A and Sawynok J: Antinociception by
adenosine analogs and inhibitors of adenosine metabolism in an
inflammatory thermal hyperalgesia model in the rat. Pain.
74:235–245. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ma HC, Wang YF, Feng CS, Zhao H and Dohi
S: Effects of adenosine agonist R-phenylisopropyl-adenosine on
halothane anesthesia and antinociception in rats. Acta Pharmacol
Sin. 26:181–185. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lavand'homme PM and Eisenach JC: Exogenous
and endogenous adenosine enhance the spinal antiallodynic effects
of morphine in a rat model of neuropathic pain. Pain. 80:31–36.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Maione S, de Novellis V, Cappellacci L,
Palazzo E, Vita D, Luongo L, Stella L, Franchetti P, Marabese I,
Rossi F, et al: The antinociceptive effect of
2-chloro-2-C-methyl-N6-cyclopentyladenosine (2-Me-CCPA), a highly
selective adenosine A1 receptor agonist, in the rat. Pain.
131:281–292. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sjölund KF, Sollevi A, Segerdahl M,
Hansson P and Lundeberg T: Intrathecal and systemic
R-phenylisopropyl-adenosine reduces scratching behaviour in a rat
mononeuropathy model. Neuroreport. 7:1856–1860. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Goadsby PJ, Hoskin KL, Storer RJ,
Edvinsson L and Connor HE: Adenosine A1 receptor agonists inhibit
trigeminovascular nociceptive transmission. Brain. 125:1392–1401.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen JF, Sonsalla PK, Pedata F, Melani A,
Domenici MR, Popoli P, Geiger J, Lopes LV and de Mendonça A:
Adenosine A2A receptors and brain injury: Broad spectrum of
neuroprotection, multifaceted actions and ‘fine tuning’ modulation.
Prog Neurobiol. 83:310–331. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Takahashi RN, Pamplona FA and Prediger RD:
Adenosine receptor antagonists for cognitive dysfunction: A review
of animal studies. Front Biosci. 13:2614–2632. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Moro S, Gao ZG, Jacobson KA and Spalluto
G: Progress in the pursuit of therapeutic adenosine receptor
antagonists. Med Res Rev. 26:131–159. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ledent C, Vaugeois JM, Schiffmann SN,
Pedrazzini T, El Yacoubi M, Vanderhaeghen JJ, Costentin J, Heath
JK, Vassart G and Parmentier M: Aggressiveness, hypoalgesia and
high blood pressure in mice lacking the adenosine A2a receptor.
Nature. 388:674–678. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sebastião AM, Macedo MP and Ribeiro JA:
Tonic activation of A(2A) adenosine receptors unmasks, and of A(1)
receptors prevents, a facilitatory action of calcitonin
gene-related peptide in the rat hippocampus. Br J Pharmacol.
129:374–380. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cunha-Reis D, Ribeiro JA and Sebastião AM:
A1 and A2A receptor activation by endogenous adenosine is required
for VIP enhancement of K+-evoked [3H]-GABA
release from rat hippocampal nerve terminals. Neurosci Lett.
430:207–212. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang Q, Yang T, Zhou M and Zhou D:
Effects of Tianshu capsule on plasma NO, NOS, CGRP contents and
hemodynamic of migraine animal models. J Clin Neurol. 21:279–282.
2008.
|
|
29
|
Tianhua YZ, Zhou M, Liu Y and Zhou D:
Effect of Tianshu capsule on the plasma levels of β-endorphin and
5-Hydroxytryptamine and c-fos expression of brain tissue in
migraine rats. J Clin Neurol. 21:368–370. 2008.
|
